Tiaojing Cuyun Recipe Enhances Pregnancy Outcome via the VEGF/PI3K/AKT/eNOS Signaling Pathway in EID Mice

Huang, Hongli; Xia, Lei; Xia, Yanqiu; Yan, Yunping; Jiang, Zhuojun; Zhao, Pei; Dong, Li

doi:https://doi.org/10.1155/2022/9461444

Disease Markers

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Disclosure Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 9461444 | https://doi.org/10.1155/2022/9461444

Tiaojing Cuyun Recipe Enhances Pregnancy Outcome via the VEGF/PI3K/AKT/eNOS Signaling Pathway in EID Mice

Hongli Huang,¹Lei Xia,¹Yanqiu Xia,¹Yunping Yan,¹Zhuojun Jiang,¹Pei Zhao,²and Li Dong¹

Academic Editor: Azizah Ugusman

Received02 Aug 2021

Accepted09 Feb 2022

Published24 Feb 2022

Abstract

Purpose. In this study, we evaluated the effect of Tiaojing Cuyun Recipe (TJCYR) on embryo implantation dysfunction- (EID-) induced damage of endometrial receptivity in mice and investigated the mechanisms underlying the effect. Methods. The main compounds of TJCYR were identified by high-performance liquid chromatography (HPLC). One hundred and twenty pregnant mice were randomly divided into six groups: control, EID only, progesterone (Prog)+EID, TJCYR-low-dose+EID, TJCYR-medium-dose+EID, and TJCYR-high-dose+EID. Mifepristone was injected to make the EID model. On the fourth day of pregnancy, serum was obtained to analyze hormone level by radioimmunoassay, the uterus was collected to analyze morphology by hematoxylin and eosin (H&E) and scanning electron microscopy (SEM), and a combination of immunofluorescence and Western blot was used to identify the related proteins. On the eighth day of pregnancy, the mice were sacrificed and the number of uterus-implanted blastocysts was counted. Results. Treatment with TJCYR significantly improved the number of implanted sites, the number of well-developed pinopodes, and microvascular formation in the mice. Moreover, TJCYR significantly activated PI3K/Akt/eNOS signaling pathways to promote angiogenesis, resulting in significantly improved endometrial receptivity and fertility outcomes when compared to the model group. Conclusion. These findings demonstrate that TJCYR was able to protect embryo implantation of EID mice due to TJCYR-mediated improvement in endometrial receptivity by promoting endometrial angiogenesis.

1. Introduction

The incidence of infertility has been a global health problem among women [1]. While access to assisted reproductive technology (ART) has overcome the majority of infertility causes, success rates have stagnated at around 30% [2]. Successful pregnancy inevitably depends on high embryo quality and good endometrial receptivity. During pregnancy, the endometrium apical surface undergoes several morphological, molecular, and biochemical changes to provide a favorable environment for embryo implantation, thereby creating an effective maternal-fetal interaction [3]. Thus, endometrial receptivity is key to raising the pregnancy rate in women with infertility [4–6]. Attempts at focusing on improvement of endometrial receptivity have been made in recent years, such as enhancing microcirculation and trophoblast invasion [7]. During the reproductive processes, the supply of essential nutrients and oxygen from vasculature is very important for the development of maternal-fetal interaction. It has been reported that the endometrium thickens with mature vascular network and increased blood flow, which reflect sufficient endometrial receptivity and, in particular, determine the endometrial response to the blastocyst at the early stage of embryo implantation [8]. Thus, enhanced endometrial angiogenesis is one of the important biological events during the reproductive cycle and pregnancy.

Traditional Chinese Medicine has gained wide acceptance due to its advantages of multifactorial and multitarget actions. In our clinical practice, we found that Tiaojing Cuyun Recipe (TJCYR) clearly enhanced the rate of pregnancy in women with infertility. Some studies reported that TJCYR may regulate follicular development and elevate the pregnancy rate in anovulatory infertility patients with kidney deficiency syndrome and significantly improve the ovulation rate and the reproductive function of the endocrine axis in androgen-sterilized rats [9, 10]. It has been reported that Bushen Huoxue Formula, which is composed of TJCYR, can improve the ACT-INH-FS system in patients with polycystic ovary syndrome with kidney deficiency and blood stasis [11]. Experimental studies have also demonstrated that Epimedium brevicornu Maxim. and Morinda officinalis How. improve endometrial receptivity in ovulation stimulation (OS) in EID mice through significant improvements in the spatial and temporal expression of pinopodes, accompanied by a significantly increased number of embryonic implantation sites [12]. These effects are desirable and satisfactory, but the therapeutic mechanism of TJCYR is not yet fully elucidated. The aim of this study was to provide a detailed account of the beneficial effect of TJCYR on EID-induced damage to endometrial receptivity in mice and to investigate its mechanism of action. From this perspective, we attempted to find novel candidates from traditional medicinal herbs to enhance the pregnancy outcome.

2. Materials and Methods

2.1. Medicine Preparation

TJCYR consists of seven herbs (Table 1). All herbs were supplied by the Shanghai Kangqiao Chinese Medicine Tablet Co., Ltd. (Shanghai, China). The decoction component mixture was added with water of 4 times volume, boiled twice, concentrated using a rotary evaporator, and attained the equivalent crude content of 2.0 g/mL. The concentrations of 12 g/kg, 24 g/kg, and 48 g/kg of the preparations were designated as TJCYR-L, TJCYR-M, and TJCYR-H, respectively.

2.2. Identification of Chemical Constituents in TJCYR by High-Performance Liquid Chromatography (HPLC)

The active ingredients of TJCYR were examined using the 1200 series HPLC device (Agilent Technologies, Santa Clara, CA, USA) with an autosampler (G1329B), thermostatted column compartment (G1316A), quaternary pump (G1311A), photodiode array detector (G1315D), and degasser (G1322A). HPLC was performed on an Apollo C18 ( mm; particle size, 5 μm; GRACE, Columbia, Maryland, USA) with a mobile phase of acetonitrile (A) -0.1% () and phosphoric acid (B) for gradient elution (0–70 min, 1-40% A; 70-90 min, 40-80% A). The detection wavelength was 260 nm, and the flow rate was 1 mL/min. The column temperature was 30°C, and the injection volume was 10 μL. The standard solutions of Calycosin-7-glucoside, Acteoside, Salvianolic acid B, Icariin, Tanshinone IIA, and sample were filtered with a 0.45 μm membrane filter before subjecting them to HPLC analysis.

2.3. Reagents

Mifepristone and progesterone were obtained from the pharmacy department of Yueyang Hospital of Integrative Traditional Chinese and Western Medicine; hematoxylin-eosin, Antifade Polyvinylpyrrolidone Mounting Medium, and nitric oxide (NO) assay kit were purchased from Beyotime (China); the antibodies ERα, ERβ1, PR, Integrin αV, Integrin β3, OPN, LIF, eNOS, and p-eNOS were purchased from Abcam (UK); vascular endothelial growth factor (VEGF) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from Proteintech (USA); Alexa Fluor 488 nm, Alexa Fluor 555 nm, Akt, p-Akt, and β-tubulin were purchased from CST (USA); Lycopersion Esculentum Lectin was purchased from Vector Laboratories (USA); DAPI was purchased from Sigma (USA); chemiluminescence detection kit was purchased from Millipore (USA).

2.4. Animals

Adult female and male Kunming mice (weighing 25-28 g) were purchased from Beijing Vital River Laboratory Animal Technology Co, Ltd. (Beijing, China; SCXK(J)2016-0011). All experimental protocols were approved by the Animal Care and Use Committee of Shanghai University of Traditional Chinese Medicine (Shanghai, China, PZSHUTCM200703008). The mice were housed in cages separately with controlled temperature and humidity, 12 h light-dark periods, and free access to water and a standard diet. The two estrous cycles were observed by using vaginal smears in female mice before the treatment.

2.5. Treatments and Establishment of EID

The female mice were mixed with male mice in a ratio of 2 : 1 to mate overnight in the independent cages. The following morning, the presence of a vaginal plug was considered as an indicator of successful copulation, and this day was classified as day 1 of pregnancy (Pd1). The pregnant mice were then randomly divided into six experimental groups ( in each group), including the control, EID only, progesterone (Prog)+EID, TJCYR-low-dose+EID, TJCYR-medium-dose+EID, and TJCYR-high-dose+EID. In the control and EID-only groups, the mice were given intragastric administration of physiological saline solution once daily for 4 days; the treatment group was given Prog and TJCYR, respectively. Mifepristone (0.1 mg/mouse) was subcutaneously injected at Pd4 in the morning, to establish the EID model [13]. Mice were sacrificed on Pd4 and Pd8, respectively. We obtained blood samples from the orbital vein on Pd4, and the serum was collected to detect hormone levels. The number of implantation sites on Pd8 was recorded. The uteri were harvested on Pd4 to evaluate endometrial receptivity and the potential mechanism. The procedure followed in this experiment is shown in Figure 1(a).

(a)

(b)

2.6. Hematoxylin and Eosin (H&E) Staining

The uteri were dissected and fixed in 4% paraformaldehyde and embedded in paraffin, then serially sectioned at a thickness of 5 μm. Sections were stained with H&E for morphological measurements. The slides were mounted after H&E staining and were examined using an optical microscope (Stemi DV4, Carl Zeiss, Oberkochen, Germany).

2.7. Scanning Electron Microscopy (SEM)

The endometria were sliced and fixed in 1.25% () glutaraldehyde solution and 1% osmium tetroxide at 4°C for 2 h, respectively. The samples were dehydrated through graded concentrations of ethanol and subsequently dried in a critical-point drier with carbon dioxide, then mounted onto the specimen holder and coated with gold palladium. Finally, all specimens were observed under the SEM (SU8010, Hitachi Instruments, Tokyo, Japan).

2.8. Immunofluorescence Staining

Isolated uteri were frozen in optimal cutting temperature compound (OCT) in liquid nitrogen and were serially frozen-sectioned at 8 μm thick. Nonspecific proteins were blocked with 5% fetal bovine serum for 1 h at room temperature (RT). The sections were then incubated with primary antibodies (ERα, 1 : 200; ERβ1, 1 : 500; PR, 1 : 200; Integrin αV, 1 : 200; Integrin β3, 1 : 100; OPN, 1 : 500; LIF,1 : 500) or fluorescence probe (Lycopersion Esculentum Lectin) overnight at 4°C. The next day, the sections were incubated with the Alexa Fluor 488 nm (green) or Alexa Fluor 555 nm (red) for 1 h at RT in dark, then stained with DAPI (blue). After rinsing three times with PBST, the slides were mounted with Antifade Polyvinylpyrrolidone Mounting Medium and then covered with coverslips. Finally, images were obtained using a Carl Zeiss LSM800 confocal microscope (Carl Zeiss Microscope GmbH, Jena, Germany).

2.9. Quantification of NO Content

NO concentration in uterus tissue was measured with the NO assay kit following the user manual. The quantitative determination of nitrite levels represents NO content.

2.10. Western Blotting

The uterus tissue was mixed with lysis buffer and the protease inhibitor, then the samples were homogenized and centrifuged, and the supernatants were collected. After determining the protein concentration, the lysates were separated by 10% SDS-PAGE and then transferred to PVDF (0.45 μm, EMD Millipore, Billerica, MA, USA). The membranes were blocked with 5% nonfat milk for 1 h at RT and then probed overnight at 4°C with primary antibodies ERα (1 : 1000), ERβ1 (1 : 1000), PR (1 : 1000), Integrin αV (1 : 1000), Integrin β3 (1 : 1000), OPN (1 : 500), LIF (1 : 1000,), VEGF (1 : 1000), Akt (1 : 1000), p-Akt (1 : 1000), eNOS (1 : 1000), p-eNOS (1 : 1000), GAPDH (1 : 3000), or β-tubulin (1 : 1000). Next, the membranes were washed and incubated with the appropriate secondary antibody for 1 h at RT. Finally, signals were detected using a chemiluminescence detection kit (EMD Millipore, Billerica, MA, USA) and the FluorChem E imaging system (ProteinSimple, San Francisco, CA, USA); the protein band densities were quantified by using an image analysis system (Alpha View SA, ProteinSimple, San Francisco, CA, USA) and expressed as ratios to GAPDH or β-tubulin.

2.11. Statistical Analysis

All results were expressed as . Differences were compared by one-way analysis of variance (ANOVA) and were considered significant at . All statistical tests were performed with GraphPad Prism software version 5.0.

3. Results

3.1. Quality Evaluation of TJCYR by HPLC

According to the Pharmacopoeia of the People’s Republic of China (2020 version), the indicative quality control components of the TJCYR are Calycosin-7-glucoside (standard substance for Astragalus membranaceus (Fisch.) Bunge), Acteoside (standard substance for Rehmannia glutinosa (Gaert.) Libosch.ex Fisch.et Mey.), Salvianolic acid B (standard substance for Salvia miltiorrhiza Bge.), Icariin (standard substance for Epimedium brevicornu Maxim.), and Tanshinone IIA (standard substance for Salvia miltiorrhiza Bge.), respectively. In this study, we established a method for determination of multiple indicator compounds by HPLC, which can effectively determine multiple indicator components in the compound at the same time. The results are shown in Figure 1(b). HPLC chromatographic results showed that the indicator components of these TCM components in the recipe were effectively transferred to the extract during water decocting. That is, TJCYR could play efficacy in the mice treated with TJCYR by intragastric administration. It well guaranteed the quality and pharmacodynamics of TJCYR.

3.2. TJCYR Enhancement of Blastocyst Implantation

The numbers of blastocyst sites were recorded on Pd8. As indicated in Figure 2, the embryos appear well-developed and show a string-of-beads arrangement in the control group, while the embryos were markedly tiny and runtish in the EID group, which suggested that the EID was a successful model. Treatment with TJCYR increased the implantation numbers and profoundly promoted the development and distribution of the embryos, especially in mice administered with TJCYR-H, so this treatment was used in the following study.

(a)

(b)

3.3. TJCYR Improved EID-Induced Endometrium Morphological Changes

For HE and SEM, all samples were assigned a random number to minimize technical and investigator bias by a double-blinded way. The HE and SEM were read by the professional of pathology and electron microscope in Science and Technology Experiment Center of Shanghai University of Traditional Chinese Medicine, respectively. And then, data was analyzed to reveal the result of morphological changes in every group. As shown in Figure 3(a), H&E staining was used to evaluate the pathological changes of the endometrium. In the EID-only group, loose endometrial stromal tissue and insufficient glands and vessels were found, in contrast to the mice treated with TJCYR. To further assess the morphological TJCYR-related changes on EID, we investigated the effect of TJCYR on the pinopodes using SEM. As shown in Figure 3(b), in the control group, the majority of well-developed pinopodes were evenly distributed over the endometrial epithelial surfaces, while on EID-induced surfaces, well-developed pinopodes were sparse and a few developing pinopodes were seen. However, the pinopodes in this group improved significantly following treatment with TJCYR. The results suggest that TJCYR can improve the endometrial morphology and vasculature in an EID model, with benefits for embryo implantation.

(a)

(b)

3.4. The Effect of TJCYR on Hormones and Hormone Receptors

The receptive mouse uterus displays stromal proliferation and epithelial differentiation, indicating readiness for blastocyst implantation, and is governed by ovarian hormones, such as 17β-estradiol (E₂) and progesterone (P₄). We tested the serum content of E₂ and P₄ in the serum. For the hormonal analysis, all samples were also randomly assigned; the test of hormone was conducted by Shanghai Xinfan Biological Technology Co., Ltd. And the results were analyzed in a double-blind way. We found similar E₂ level in the EID only and control groups, but the level of P₄ was notably reduced in the EID only group. Treatment with TJCYR may inhibit the P₄ decrease induced by EID. The primary mediators of these E₂- and P₄-induced events are their receptors, estrogen receptor (ER) and progesterone receptor (PR). We also test the expression of ER and PR by immunofluorescence (IF) and Western blot (WB). ER include ER-alpha (ERα) and ER-beta1 (ERβ1). The result of IF showed that the fluorescence intensity of ERα in the EID-only group was slightly weaker than in the controls, and no difference was found in the fluorescence intensity of ERβ1 between the EID-only group and the control group. However, the fluorescence intensity of PR was clearly weaker in the EID-only group than that in the control group, and treatment with TJCYR could enhance the expression of PR. In the WB, we also found that PR protein was clearly decreased in the EID-only group and that TJCYR could reverse that change. These results show that the changes in P₄ and PR were clearly apparent in the EID model and that treatment with TJCYR could regulate P₄ and PR (Figure 4).

(a)

(b)

(c)

(d)

Figure 4

Effect of TJCYR on EID-induced changes in the hormones and receptors. (a) Representative confocal fluorescent images of the uterine sample with ERα (green), ERβ1 (red), and PR (green), respectively (×20, ). (b) Protein levels of ERα, ERβ1, and PR in uterine tissue were determined by Western blotting (); (c) quantification of protein levels. (d) The serum levels of E₂ and P₄ were tested by radioimmunoassay. Results are expressed as . and versus control; ^# versus EID only. EID: embryo implantation dysfunction; Prog: progesterone; TJCYR: Tiaojing Cuyun Recipe; E₂: 17β-estradiol; P₄: progesterone; ERα: estrogen receptor alpha; ERβ1: estrogen receptor beta1; PR: progesterone receptor.

3.5. The Treatment of TJCYR Increases Endometrial Receptivity-Related Markers

Several molecular markers are related to endometrial receptivity, including Integrin αV, Integrin β3, LIF, and OPN. As shown in Figure 5, immunofluorescence and Western blot analysis showed that the expression of Integrin αV, Integrin β3, LIF, and OPN significantly decreased in the EID-only group. TJCYR was found to attenuate the EID-induced damage by increasing the expression of Integrin αV, Integrin β3, LIF, and OPN. These results are consistent with the changes found in pinopodes as shown in Figure 3(b).

(a)

(b)

(c)

Figure 5

Effect of TJCYR on the biomarkers of endometrial receptivity. (a) Representative confocal fluorescent images of the uterine sample with Integrin αV, Integrin β3, LIF, and OPN, respectively (×20, ). (b) Protein levels of Integrin αV, Integrin β3, LIF, and OPN in uterine tissue were determined by Western blotting (); (c) Quantification of protein levels. Results are expressed as . , , and versus control; ^# and ^## versus EID only. EID: embryo implantation dysfunction; Prog: progesterone; TJCYR: Tiaojing Cuyun Recipe.

3.6. TJCYR Treatment Promotes Endometrial Angiogenesis

Angiogenesis is one of the important biological events which may be involved in implantation. Tomato Lectin is recognized as the most sensitive vessel marker, the fluorescence intensity of which may reflect vascular density. As shown in Figure 6(a), high immunofluorescence was detected using Tomato Lectin in the control and TJCYR treatment groups, while the immunofluorescence appeared weak in the EID only group. In contrast, microvascular density was dramatically enhanced in the TJCYR group. VEGF is an important mediator of angiogenesis with beneficial effects on endometrial receptivity and plays a key role in the embryonic development of mice. As shown in Figures 6(b) and 6(c), treatment with TJCYR clearly inhibited the decrease of VEGF in mice subjected to EID, which is consistent with the immunofluorescence analysis (Figure 6(a)) which showed increased vascular density.

(a)

(b)

(c)

3.7. TJCYR Improved Angiogenesis through the PI3K/Akt/eNOS Signaling Pathway

The PI3K/Akt/eNOS pathway is downstream of VEGF, which participates in angiogenesis. Here, we found that the expressions of p-Akt and p-eNOS were all reduced in the EID-only group compared to the control group, accompanied by a decline in NO. All of these decreased expressions were restored by treatment with TJCYR (Figure 7). These data suggest that TJCYR stimulated the PI3K/Akt/eNOS signaling pathway, which was deactivated by EID.

(a)

(b)

(c)

4. Discussion

Successful embryo implantation is a highly orchestrated process involving blastocyst-uterine interactions. While blastocyst quality has been extensively studied, endometrial receptivity is equally important. Endometrial receptivity is defined as “that period of endometrial maturation during which the trophectoderm of the blastocyst can attach to the endometrial epithelial cells and subsequently proceed to invade the endometrial stroma and vasculature” [14]. Therefore, improving endometrial receptivity is key to raising the pregnancy rate. The pinopodes have been considered as the characteristic morphologic markers of endometrial receptivity and of the implantation window [13, 15]. The pinopodes are membrane protrusions on the apical surface of luminal epithelium on Pd4 in mice. They prevent cilia from sweeping the blastocyst away as well as promoting withdrawal of uterine fluid and closure of the uterine cavity [4, 16]. In our study, the specimens were examined by SEM to detect pinopodes. The results revealed that TJCYR may enhance the number of fully developed pinopodes, accompanied by reduced distribution of cilia, which may provide nutrients for the embryo and enable its attachment to the uterine endometrium. The pinopodes play a key role in the initial stage of implantation by promoting attachment of the embryo.

The endometrium is the most direct target organ for estrogen and progesterone, among which E2 and P4 are the most important regulatory factors. The formation of pinopodes depends on the influence of estrogen and progesterone, the physiological effects of which depend on the mediation of estrogen receptors and progesterone receptors in endometrial glandular epithelial cells [17]. Therefore, estrogen, progesterone, and their receptors are important factors for the formation of good endometrial receptivity. Some studies [18, 19] have shown that the establishment of endometrial receptivity requires sufficient estrogen stimulation before ovulation and the supportive effect of progesterone on the endometrium after ovulation. In this study, we described the protective effects of TJCYR against EID, and we found that progesterone and its receptor were increased notably with TJCYR treatment.

Pregnancy is a versatile and dynamic process for the implanting embryo, requiring a series of rather complicated and synchronous morphological and biochemical changes. The appearance of pinopodes is consistent with the expression of several molecular markers of endometrial receptivity, including Integrin, leukemia inhibitory factor (LIF), and osteopontin (OPN). It is meaningful to analyze pinopodes and the molecular biomarkers together, hence our further studies exploring the effect of TJCYR on the expression of Integrin, LIF, and OPN. Integrins are cell surface receptors that are involved in cell-to-cell and extracellular matrix adhesion. Some Integrins increase during the implantation window. There are many isoforms of Integrins in mammals, but only three (α1β1, α4β1, and αVβ3) have been found to have roles in implantation, αVβ3 playing the most conspicuous role [16]. Integrin αVβ3 is a potential receptor for blastocyst attachment and is localized on pinopodes [16]. Some studies have revealed that blockage of Integrin αVβ3 or lack of Integrin β3 may be related to unexplained infertility [20]. LIF is a member of the interleukin-6 family of cytokines, which plays a critical role in implantation. Pinopodes release secretory vesicles containing LIF in the uterine lumen to enable trophoblast invasion and affecting immune tolerance during implantation [16, 21]. Some studies [22] have shown that the deletion or mutation of LIF induced implantation failure. Other studies [23, 24] reported that endometrial LIF and receptor were higher around the time of implantation in fertile women compared with women with unexplained infertility. Other findings [25] have shown that LIF may maintain the proper development of the endometrium and implantation receptivity by regulating downstream target genes. OPN is one of the cofactors involved in cell adhesion and invasion during the implantation process, is an acidic member of the small integrin-binding ligand family of proteins [26], and has been shown to be maximally expressed in the epithelial layer in human, mouse, and rabbit uterine. OPN is therefore an important constituent of the uterus during pregnancy [26, 27]. In this study, the EID group showed histopathological lesion characteristic of pinopodes, as well as low expression of Integrin αV, Integrin β3, LIF, and OPN, while the expression of these biochemical markers was significantly increased in mice treated with TJCYR. These data strongly demonstrate the benefits of TJCYR in endometrial receptivity.

During the implantation window, a rich vascular network is necessary to supply nutrients and oxygen. As is well known, oxygen is abundant where blood supply is rich [28]. In clinical practice, blood flow scanning is the current and preferred approach for assessing endometrial function [29]. It is well established that proper endometrial vascular development and maintenance are crucial for successful pregnancy [30]. Insufficient angiogenesis may result in poor endometrial receptivity [31]. Based on Lectin immunostaining showing higher vascular density in TJCYR treatment, we next explored whether VEGF expression is increased with this treatment. VEGF has a predominant role in successful implantation and maintenance of pregnancy by increasing vascular permeability or forming vascular networks. It has been reported that VEGF knockout mice do not produce viable offspring [32]. The expression of VEGF increases significantly during implantation windows, which suggests that it promotes angiogenesis and the establishment of capillary networks, further improving endometrial receptivity and promoting embryo implantation [33]. Alternatively, deficiency of VEGF may induce the reduction of angiogenesis at the implantation site and lead to miscarriage [34]. VEGF inhibitors are used to achieve contraception [35]. In this study, we found a poor vascular network in the mice treated with EID only; that treatment with TJCYR significantly inhibited the decline in vessel density and expression of VEGF in the EID-only group and improved endometrial blood circulation. All the data showed that VEGF regulated angiogenesis and built endometrial microenvironment for embryo implantation.

It is well known that, as the downstream signaling pathway of VEGF, the activated PI3K/Akt pathway regulates cell proliferation, differentiation, apoptosis, cell cycle, protein synthesis, cell energy metabolism, and other functions [36, 37]. It had been demonstrated that the role of the PI3K/Akt pathway may vary completely with conditions. In this study, we found that after the PI3K/Akt signaling pathway was activated by increased VEGF, the eNOS was sequentially activated. eNOS acts as a key regulator of angiogenesis by mediating the speed of NO enzyme generation. NO is an important angiogenic substance produced by healthy endothelial cells to support vascular homeostasis and blood flow. During the reproductive processes, NO plays a critical role in maintaining blood vessel stability at the implantation site, further safeguarding embryo implantation and pregnancy maintenance. In the present study, we found that the expressions of p-Akt and p-eNOS were all reduced in the EID mice compared to the control group. Conversely, treatment with TJCYR markedly increased the expression of VEGF and subsequently increased the activation of the PI3K/Akt/eNOS pathway.

5. Conclusion

The results of the present study revealed that TJCYR can activate the PI3K/AKT/eNOS signaling pathway to improve endometrial microcirculation and blood flow, enhancing endometrial receptivity and embryo implantation, which were correlated with the characteristic changes in endometrial morphology and the upregulation of molecular markers for endometrial receptivity.

Data Availability

The data are available upon direct request to the corresponding author.

Disclosure

Part of the manuscript has previously been presented as a preprint in doi:10.21203/rs.3.rs-132200/v1 available via the following link: https://www.researchsquare.com/article/rs-132200/v1

Conflicts of Interest

The authors declare that they have no conflict of interest regarding the publication of this paper.

Authors’ Contributions

Li Dong conceived the study and designed the experiments. Hongli Huang, Lei Xia, Yanqiu Xia, Yunping Yan, Zhuojun Jiang, and Pei Zhao performed the experiments. Hongli Huang, Lei Xia, and Pei Zhao analyzed the data. Pei Zhao drafted the manuscript. Li Dong reviewed and revised the manuscript. Li Dong and Pei Zhao contributed equally to this paper. Hongli Huang and Lei Xia contributed equally to this work.

Acknowledgments

This study was funded by the Shanghai Science and Technology Committee project (No. 16401931900), the Natural Science Foundation of Shanghai (No. 16ZR1438000), the “Three-year” Development Project of Shanghai Shenkang Hospital Development Center (No. 16CR3040A), and the Budget Research Project of Shanghai Education Commission (No. 2019LK091).

References

J. C. Harper, K. Aittomäki, P. Borry et al., “Recent developments in genetics and medically assisted reproduction: from research to clinical applications,” Human Reproduction Open, vol. 2017, no. 3, 2017.
View at: Publisher Site | Google Scholar
E. R. Norwitz, D. J. Schust, and S. J. Fisher, “Implantation and the survival of early pregnancy,” The New England Journal of Medicine, vol. 345, no. 19, pp. 1400–1408, 2001.
View at: Publisher Site | Google Scholar
L. A. Salamonsen, T. Edgell, L. J. F. Rombauts et al., “Proteomics of the human endometrium and uterine fluid: a pathway to biomarker discovery,” Fertility and Sterility, vol. 99, no. 4, pp. 1086–1092, 2013.
View at: Publisher Site | Google Scholar
H. Matsumoto, “Molecular and cellular events during blastocyst implantation in the receptive uterus: clues from mouse models,” The Journal of Reproduction and Development, vol. 63, no. 5, pp. 445–454, 2017.
View at: Publisher Site | Google Scholar
J. Cha, X. Sun, and S. K. Dey, “Mechanisms of implantation: strategies for successful pregnancy,” Nature Medicine, vol. 18, no. 12, pp. 1754–1767, 2012.
View at: Publisher Site | Google Scholar
J. A. Miravet-Valenciano, A. Rincon-Bertolin, F. Vilella, and C. Simon, “Understanding and improving endometrial receptivity,” Current Opinion in Obstetrics & Gynecology, vol. 27, no. 3, pp. 187–192, 2015.
View at: Publisher Site | Google Scholar
X. Yu, C. Gao, C. Dai, F. Yang, and X. Deng, “Endometrial injury increases expression of hypoxia-inducible factor and angiogenesis in the endometrium of women with recurrent implantation failure,” Reproductive BioMedicine Online, vol. 38, no. 5, pp. 761–767, 2019.
View at: Publisher Site | Google Scholar
A. Kim, H. Jung, W. J. Choi, S. N. Hong, and H. Y. Kim, “Detection of endometrial and subendometrial vasculature on the day of embryo transfer and prediction of pregnancy during fresh in vitro fertilization cycles,” Taiwanese Journal of Obstetrics & Gynecology, vol. 53, no. 3, pp. 360–365, 2014.
View at: Publisher Site | Google Scholar
Y. Lin and L. Dong, “Treatment of anovulatory infertility with shen deficiency syndrome by ZHU’s Tiaojing Cuyun Recipe: a clinical evaluation,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 35, no. 10, pp. 1181–1185, 2015.
View at: Google Scholar
H. L. Huang, L. Xia, Y. Q. Xia, Y. P. Yan, Z. J. Jiang, and L. Dong, “Effect of Tiaojing Zhuyun Recipe on ovulation induction in androgen-causing sterile rats,” Journal of Shanghai University of Traditional Chinese Medicine, vol. 29, no. 2, pp. 61–66, 2015.
View at: Google Scholar
J. Tao and L. Dong, “Effect of Bushen Huoxue formula on ACT-INH-FS system in patients with polycystic ovary syndrome of the kidney deficiency and blood stasis pattern,” Shanghai Journal of Traditional Chinese Medicine, vol. 48, no. 7, pp. 58–61, 2014.
View at: Google Scholar
N. Yu, W. Yan, Y. Wang, T. Yin, Y. Guo, and J. Yang, “Effect of Zhuyun recipe on endometrial pinopode expression in mice with embryonic implantation dysfunction and ovulation stimulation,” Experimental and Therapeutic Medicine, vol. 9, no. 2, pp. 488–492, 2015.
View at: Publisher Site | Google Scholar
D. M. Huang, L. G. Nardo, G. Y. Huang, F. E. Lu, and Y. J. Liu, “Effect of a single dose of mifepristone on expression of pinopodes in endometrial surface of mice,” Acta Pharmacologica Sinica, vol. 26, no. 2, pp. 212–219, 2005.
View at: Publisher Site | Google Scholar
B. A. Lessey and S. L. Young, “What exactly is endometrial receptivity?” Fertility and Sterility, vol. 111, no. 4, pp. 611–617, 2019.
View at: Publisher Site | Google Scholar
K. E. Quinn, B. C. Matson, M. Wetendorf, and K. M. Caron, “Pinopodes: recent advancements, current perspectives, and future directions,” Molecular and Cellular Endocrinology, vol. 501, 2020.
View at: Publisher Site | Google Scholar
F. Z. Rarani, F. Borhani, and B. Rashidi, “Endometrial pinopode biomarkers: molecules and microRNAs,” Journal of Cellular Physiology, vol. 233, no. 12, pp. 9145–9158, 2018.
View at: Publisher Site | Google Scholar
M. Wetendorf and F. J. DeMayo, “The progesterone receptor regulates implantation, decidualization, and glandular development via a complex paracrine signaling network,” Molecular and Cellular Endocrinology, vol. 357, no. 1-2, pp. 108–118, 2012.
View at: Publisher Site | Google Scholar
C. Zijiang and Y. Junhao, “Latest research advances on factors that influence endometrial receptivity,” Journal of Shandong University, vol. 59, no. 8, pp. 1–7, 2021.
View at: Google Scholar
F. E. I. Gong, X. Li, S. Zhang et al., “A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome,” Experimental and Therapeutic Medicine, vol. 10, no. 5, pp. 1865–1870, 2015.
View at: Publisher Site | Google Scholar
A. Germeyer, R. F. Savaris, J. Jauckus, and B. Lessey, “Endometrial beta3 integrin profile reflects endometrial receptivity defects in women with unexplained recurrent pregnancy loss,” Reproductive Biology and Endocrinology, vol. 12, no. 1, pp. 53–57, 2014.
View at: Publisher Site | Google Scholar
M. Kabir-Salmani, H. Nikzad, S. Shiokawa, Y. Akimoto, and M. Iwashita, “Secretory role for human uterodomes (pinopods): secretion of LIF,” Molecular Human Reproduction, vol. 11, no. 8, pp. 553–559, 2005.
View at: Publisher Site | Google Scholar
H. Achache and A. Revel, “Endometrial receptivity markers, the journey to successful embryo implantation,” Human Reproduction Update, vol. 12, no. 6, pp. 731–746, 2006.
View at: Publisher Site | Google Scholar
L. Aghajanova, “Leukemia inhibitory factor and human embryo implantation,” Annals of the New York Academy of Sciences, vol. 1034, no. 1, pp. 176–183, 2004.
View at: Publisher Site | Google Scholar
E. Dimitriadis, C. Stoikos, M. Stafford-Bell et al., “Interleukin-11, IL-11 receptoralpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window,” Journal of Reproductive Immunology, vol. 69, no. 1, pp. 53–64, 2006.
View at: Publisher Site | Google Scholar
J. G. Cheng, J. R. Chen, L. Hernandez, W. G. Alvord, and C. L. Stewart, “Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 15, pp. 8680–8685, 2001.
View at: Publisher Site | Google Scholar
G. A. Johnson, R. C. Burghardt, F. W. Bazer, and T. E. Spencer, “Osteopontin: roles in implantation and placentation1,” Biology of Reproduction, vol. 69, no. 5, pp. 1458–1471, 2003.
View at: Publisher Site | Google Scholar
Y. J. Kang, K. Forbes, J. Carver, and J. D. Aplin, “The role of the osteopontin-integrin αvβ3 interaction at implantation: functional analysis using three different in vitro models,” Human Reproduction, vol. 29, no. 4, pp. 739–749, 2014.
View at: Publisher Site | Google Scholar
M. Y. Zhang, H. H. Chen, J. Tian et al., “Danggui Shaoyao San ameliorates renal fibrosis via regulation of hypoxia and autophagy,” Evidence-Based Complementary and Alternative Medicine, vol. 2019, Article ID 2985270, 10 pages, 2019.
View at: Publisher Site | Google Scholar
L. Craciunas, I. Gallos, J. Chu et al., “Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis,” Human Reproduction, vol. 25, no. 2, pp. 202–223, 2019.
View at: Publisher Site | Google Scholar
M. Zbucka, M. Koda, J. Tomaszewski, W. Przystupa, S. Sulkowski, and S. Wołczyński, “Angiogenesis in the female reproductive processes,” Ginekologia Polska, vol. 75, no. 8, pp. 649–657, 2004.
View at: Google Scholar
Q. Si and R. Liu, “Screening of angiogenesis inhibitors using a 3D vascular microfluidic chip to achieve contraception,” Biochemical and Biophysical Research Communications, vol. 515, no. 1, pp. 92–98, 2019.
View at: Publisher Site | Google Scholar
P. Licht, V. Russu, S. Lehmeyer, T. Wissentheit, E. Siebzehnrübl, and L. Wildt, “Cycle dependency of intrauterine vascular endothelial growth factor levels is correlated with decidualization and corpus luteum function,” Fertility and Sterility, vol. 80, no. 5, pp. 1228–1233, 2003.
View at: Publisher Site | Google Scholar
A. Ylikorkala, D. J. Rossi, N. Korsisaari et al., “Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice,” Science, vol. 293, no. 5533, pp. 1323–1326, 2001.
View at: Publisher Site | Google Scholar
G. E. Lash, B. A. Innes, J. A. Drury, S. C. Robson, S. Quenby, and J. N. Bulmer, “Localization of angiogenic growth factors and their receptors in the human endometrium throughout the menstrual cycle and in recurrent miscarriage,” Human Reproduction, vol. 27, no. 1, pp. 183–195, 2012.
View at: Publisher Site | Google Scholar
A. M. Sharkey, R. Catalano, A. Evans, D. S. Charnock-Jones, and S. K. Smith, “Novel antiangiogenic agents for use in contraception,” Contraception, vol. 71, no. 4, pp. 263–271, 2005.
View at: Publisher Site | Google Scholar
J. S. Yu and W. Cui, “Proliferation, survival and metabolism: the role of PI3K/Akt/mTOR signalling in pluripotency and cell fate determination,” Development, vol. 143, no. 17, pp. 3050–3060, 2016.
View at: Publisher Site | Google Scholar
P. Li, Y. Gan, Y. Xu et al., “The inflammatory cytokine TNF-α promotes the premature senescence of rat nucleus pulposus cells via the PI3K/Akt signaling pathway,” Scientific Reports, vol. 7, no. 1, 2017.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Hongli Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies